Context Therapeutics annual capital expenditures (capex)
2021
2022
2023
2024
2025
Context Therapeutics Capital Expenditures (CapEx) Growth & History (CNTX)
Context Therapeutics's capital expenditures (capex) was $33,948 for fiscal 2025.
View full Context Therapeutics company overviewContext Therapeutics annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $33,948 | $26,632 | +364.02% |
| 2024 | 2024-12-31 | $7,316 | $7,316 | — |
| 2023 | 2023-12-31 | $0 | −$36,836 | — |
| 2022 | 2022-12-31 | $36,836 | $36,836 | — |
| 2021 | 2021-12-31 | $0 | — | — |
Context Therapeutics quarterly capital expenditures (capex)
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $18,488 | $18,488 | — |
| Q1 2026 | 2026-03-31 | $37,258 | $3,310 | +9.75% |
| Q4 2025 | 2025-12-31 | $0 | $0 | — |
| Q3 2025 | 2025-09-30 | $0 | −$7,316 | — |
| Q2 2025 | 2025-06-30 | $0 | $0 | — |
| Q1 2025 | 2025-03-31 | $33,948 | $33,948 | — |
| Q4 2024 | 2024-12-31 | $0 | $0 | — |
| Q3 2024 | 2024-09-30 | $7,316 | $7,316 | — |
| Q2 2024 | 2024-06-30 | $0 | $0 | — |
| Q1 2024 | 2024-03-31 | $0 | $0 | — |
| Q4 2023 | 2023-12-31 | $0 | $0 | — |
| Q3 2023 | 2023-09-30 | $0 | $0 | — |
| Q2 2023 | 2023-06-30 | $0 | −$1,837 | — |
| Q1 2023 | 2023-03-31 | $0 | −$34,999 | — |
| Q4 2022 | 2022-12-31 | $0 | $0 | — |
| Q3 2022 | 2022-09-30 | $0 | $0 | — |
| Q2 2022 | 2022-06-30 | $1,837 | $1,837 | — |
| Q1 2022 | 2022-03-31 | $34,999 | $34,999 | — |
| Q4 2021 | 2021-12-31 | $0 | — | — |
| Q3 2021 | 2021-09-30 | $0 | — | — |
| Q2 2021 | 2021-06-30 | $0 | — | — |
| Q1 2021 | 2021-03-31 | $0 | — | — |
Context Therapeutics capital expenditures (capex) trends
Between the periods ended 2021-12-31 and 2025-12-31, Context Therapeutics's capital expenditures (capex) increased from $0 to $33,948, a change of $33,948. The latest reported quarter, Q2 2026, shows $18,488.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Context Therapeutics source filings ↗